Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03856515 · ClinicalTrials.gov registry record · NA
Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes
A NA study of Cigarette Smoking-Related Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 169
- Enrollment target
- 1
- Study location
NCT03856515: Completed NA study of Cigarette Smoking-Related Carcinoma, sponsored by M.D. Anderson Cancer Center.
NCT03856515 is a NA study of Cigarette Smoking-Related Carcinoma that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 169 participants, below the 459-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03856515, a NA study of Cigarette Smoking-Related Carcinoma, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
- 1
- Study location
Study Summary
This early phase I trial studies potential differences between men and women when switching from the use of combustible cigarettes to the National Institute on Drug Abuse's Standard Research E-Cigarette (SREC). Studying the differences between men and women may increase understanding about the effects of switching from smoking regular cigarettes to electronic cigarettes.
Primary Outcome
Mean cigarettes per day (CPD) smoked during the phase
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- DRUG Nicotine Replacement
- DEVICE Electronic Cigarette
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2022-06-02 |
| Est. Completion | 2026-01-07 |
| Phase | NA |
What the finished NCT03856515 record still lists
NCT03856515 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 459-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT03856515 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03856515 about?
NCT03856515 is a clinical study titled "Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes". This early phase I trial studies potential differences between men and women when switching from the use of combustible cigarettes to the National Institute on Drug Abuse's Standard Research E-Cigarette (SREC). Studying the differences between men and women may increase understanding about the effec...
What is the current status of trial NCT03856515?
This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2022-06-02. Estimated completion is 2026-01-07.
What conditions does trial NCT03856515 study?
This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.
What interventions are being tested in trial NCT03856515?
The interventions under investigation include: Questionnaire Administration (OTHER), Nicotine Replacement (DRUG), Electronic Cigarette (DEVICE).
Who is sponsoring clinical trial NCT03856515?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03856515 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03856515's enrollment target sits among peer trials
169 12th of 21 higher than 10 of 21 other Cigarette Smoking-Related Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Smoking Cessation Intervention Development for Homeless Youth
RECRUITING · NA
-
Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences
RECRUITING · NA
-
Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia
RECRUITING · NA
-
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI